Continuing Medical Education
This educational activity is intended for U.S. residents and fellows and ophthalmologists within the first 5 years of practice.
At the conclusion of the program, attendees will be able to:
- Improve surgical and decision-making skills
- Implement strategies to manage complications
- Compare and contrast ophthalmic treatments and technology
- Identify complicating factors in anterior segment surgery
- Assess and treat dry eye disease
- Evaluate minimally invasive glaucoma surgery options
The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality, and scientific integrity of this CME activity.
The American Society of Cataract and Refractive Surgery designates this live activity for a maximum of 13.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Notice of Off-Label Use Presentations
This program may include presentations on drugs or devices, or uses of drugs or devices that may not have been approved by the Food and Drug Administration (FDA) or have been approved by the FDA for specific uses only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or device he/she wishes to use in clinical practice. ASCRS is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASCRS of the uses, products, or techniques presented.
ASCRS fully comply with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. ASCRS also requires ADA compliance from contracted vendors and facilities. Any participant in this educational program who requires special accommodation or services should contact Pura Valdez at email@example.com by September 8, 2017.